Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling
Blanca D. López‐Ayllón, Ana de Lucas‐Rius, Laura Mendoza‐García, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11

Showing 11 citing articles:

Understanding interleukin 11 as a disease gene and therapeutic target
Stuart A. Cook
Biochemical Journal (2023) Vol. 480, Iss. 23, pp. 1987-2008
Open Access | Times Cited: 26
Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection
Juliane Lokau, Yvonne Garbers, Manuel M. Vicente, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2 -infected mice and reduces endotheliopathy
María Ángeles Rodríguez-Hernández, Mercedes Baena-Bustos, David Carneros, et al.
EBioMedicine (2024) Vol. 103, pp. 105132-105132
Open Access | Times Cited: 6
Metabolic and mitochondria alterations induced by SARS‐CoV‐2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10
Blanca D. López‐Ayllón, Silvia Marín, Marco Fariñas Fernández, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 7
Open Access | Times Cited: 5
Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target
Steven O’Reilly
Clinical & Experimental Immunology (2023) Vol. 214, Iss. 2, pp. 154-161
Open Access | Times Cited: 13
Impact of SARS-CoV-2 Wuhan and Omicron Variant Proteins on Type I Interferon Response
Marija Janevska, Evelien Naessens, Bruno Verhasselt
Viruses (2025) Vol. 17, Iss. 4, pp. 569-569
Open Access
Longitudinal Assessment of Nasopharyngeal Biomarkers Post-COVID-19: Unveiling Persistent Markers and Severity Correlations
Francisco Javier Redondo Calvo, Yoana Rabanal‐Ruiz, Gema Verdugo-Moreno, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 11, pp. 5064-5084
Open Access | Times Cited: 1
Effects of Combined Treatment with Sodium Dichloroacetate and Sodium Valproate on the Genes in Inflammation- and Immune-Related Pathways in T Lymphocytes from Patients with SARS-CoV-2 Infection with Pneumonia: Sex-Related Differences
Donatas Stakišaitis, Linas Kapočius, Vacis Tatarūnas, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 409-409
Open Access | Times Cited: 1
Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10
Blanca D. López‐Ayllón, Silvia Marín, Marco Fariñas Fernández, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Dynamic Cellular Proteome Remodeling during SARS-CoV-2 Infection. Identification of Plasma Protein Readouts
Fátima Milhano Santos, Jorge Vindel-Alfageme, Sergio Ciordia, et al.
Journal of Proteome Research (2024)
Open Access
Time-based quantitative proteomic and phosphoproteomic analysis of A549-ACE2 cells during SARS-CoV-2 infection
Fátima Milhano Santos, Jorge Vindel, Sergio Ciordia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top